Correction to: Psoriasis in systemic lupus erythematosus: a single-center experience (Clinical Rheumatology, (2017), 36, 4, (879-884), 10.1007/s10067-017-3566-0);Psoriasis in systemic lupus erythematosus: a single-center experience

Clinical Rheumatology

Volumn 36, Issue 4, 2017, Pages 879-884

  Tselios, Konstantinos ^a   Yap, Kristy Su Ying ^a   Pakchotanon, Rattapol ^a   Polachek, Ari ^a   Su, Jiandong ^a   Urowitz, Murray B ^a   Gladman, Dafna D ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Psoriasis; Systemic lupus erythematosus; Therapy

Indexed keywords

AZATHIOPRINE; ETANERCEPT; HYDROXYCHLOROQUINE; METHOTREXATE; USTEKINUMAB; ANTIRHEUMATIC AGENT;

ADULT; ANGINA PECTORIS; ARTICLE; ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEEP VEIN THROMBOSIS; DEMOGRAPHY; DETERIORATION; DISEASE ACTIVITY; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PERSONAL EXPERIENCE; PHOTOTHERAPY; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; PUSTULAR PSORIASIS; SCALP PSORIASIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC THERAPY; TOPICAL TREATMENT; TRANSIENT ISCHEMIC ATTACK; TRANSLUMINAL CORONARY ANGIOPLASTY; ADOLESCENT; LUPUS ERYTHEMATOSUS, SYSTEMIC; ONTARIO; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIRHEUMATIC AGENTS; AZATHIOPRINE; COHORT STUDIES; FEMALE; HUMANS; HYDROXYCHLOROQUINE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; METHOTREXATE; ONTARIO; PSORIASIS; YOUNG ADULT;

EID: 85011655229     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-018-4363-0     Document Type: Erratum

References (36)

1. Farrell MS, Wallace SJ, Clarke SM, Tarafder MR, McLaughlin WA (2014) Implementation of the connective tissue screening questionnaire in northeast Pennsylvania to identify comorbidities of connective tissue diseases in subjects with systemic lupus erythematosus. J Prim Care Community Health 5:134–138
2. Aikawa NE, Jesus AA, Liphaus BL, Silva CA, Carneiro-Sampaio M, Viana VS et al (2012) Organ-specific autoantibodies and autoimmune diseases in juvenile systemic lupus erythematosus and juvenile dermatomyositis patients. Clin Exp Rheumatol 30:126–131
3. Astudillo L, Sailler L, Carreiro M, Dahan S, Ollier S, Arlet P (2003) Psoriasis and systemic lupus erythematosus: a rare association with specific therapeutic problems. Ann Med Interne 154:3–6
4. Millns JL, Muller SA (1980) The coexistence of psoriasis and lupus erythematosus. An analysis of 27 patients. Arch Dermatol 116:658–663
5. Hays SB, Camisa C, Luzar MJ (1984) The coexistence of systemic lupus erythematosus and psoriasis. J Am Acad Dermatol 10:619–622
6. Zalla MJ, Muller SA (1996) The coexistence of psoriasis with lupus erythematosus and other photosensitive disorders. Acta Derm Venereol Suppl (Stockh) 195:1–15
7. Alarcon-Segovia D, Alarcon-Riquelme ME, Cardiel MH, Caeiro F, Massardo L, Villa AR et al (2005) Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis and other autoimmune diseases in 1177 lupus patients from the GLADEL cohort. Arthritis Rheum 52:1138–1147
8. Chandran V, Schentag CT, Brockbank JE, Pellett FJ, Shanmugarajah S, Toloza SM et al (2009) Familial aggregation of psoriatic arthritis. Ann Rheum Dis 68:664–667
9. Li Y, Cheng H, Zuo XB, Sheng YJ, Zhou FS, Tang XF et al (2013) Association analyses identifying two common susceptibility loci shared by psoriasis and systemic lupus erythematosus in the Chinese Han population. J Med Genet 50:812–818
10. Deng X, Su Y, Wu H, Wu R, Zhang P, Dai Y et al (2015) The role of microRNAs in autoimmune diseases with skin involvement. Scand J Immunol 81:153–165
11. Alarcon-Riquelme ME (2004) Role of RUNX in autoimmune diseases linking rheumatoid arthritis, psoriasis and lupus. Arthritis Res Ther 6:169–173
12. Konva C, Paz Z, Apostolides SA, Tsokos GC (2015) Update on the role of interleukin 17 in rheumatologic autoimmune diseases. Cytokine 75:207–215
13. Dowdy MJ, Nigra TP, Barth WF (1989) Subacute cutaneous lupus erythematosus during PUVA therapy for psoriasis: case report and review of the literature. Arthritis Rheum 32:343–346
14. Yanai H, Shuster D, Calabrese E, Mlynarsky L, Tumuluri S, Cohen RD (2013) The incidence and predictors of lupus-like reaction in patients with IBD treated with anti-TNF therapies. Inflamm Bowel Dis 19:2778–2786
15. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
16. Taylor W, Gladman DD, Heliwell P, Marchesoni A, Mease P, Mielants H, CASPAR Study Group (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665–2673
17. Canadian Psoriasis Guidelines Committee (2009) Canadian guidelines for the management of plaque psoriasis, June. http://www.dermatology.ca/psoriasisguidelines
18. Avriel A, Zeller L, Flusser D, Abu Shakra M, Halevy S, Sukenik S (2007) Coexistence of psoriatic arthritis and systemic lupus erythematosus. Isr Med Assoc J 9:48–49
19. Haake H, Koneke J, Amann K, Vom Dahl J, Janssen U (2007) Development of systemic lupus erythematosus with focal proliferative nephritis during anti-TNF-alpha therapy for psoriatic arthritis. Med Klin (Munich) 102:852–857
20. Cervera R, Khamastha MA, Font J, Sebastiani GD, Gil A, Lavilla P et al. Systemic lupus erythematosus: clinical and immunological patterns of disease expression in a cohort of 1000 patients. The European Working Party on Systemic lupus Erythematosus. Medicine (Baltimore) 1993; 72: 113–124
21. Hoffman IE, Peene I, Cebecauer L, Isenberg D, Huizinga TW, Union A et al (2005) Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus. Ann Rheum Dis 64:330–332
22. Grover C, Kashyap B, Daulatabad D, Dhawan A, Kaur IR (2016) Significance of anti-cyclic citrullinated peptide autoantibodies in immune-mediated inflammatory skin disorders with and without arthritis. Indian J Dermatol 61:510–514
23. Ziegelasch M, Van Delft MA, Wallin P, Skogh T, Magro-Checa C, Steup-Beekman GM et al (2016) Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts. Arthritis Res Ther 18:289
24. Candia L, Marquez J, Gonzalez C, Santos AM, Londono J, Valle R et al (2006) Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis. J Clin Rheumatol 12:226–229
25. Alenius GM, Berglin E, Rantapaa Dahlqvist S (2006) Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation. Ann Rheum Dis 65:398–400
26. Payet J, Goulvestre C, Biale L, Avouac J, Wipff J, Job-Deslandre C et al (2014) Anticyclic citrullinated peptide antibodies in rheumatoid and non-rheumatoid rheumatic disorders: experience with 1162 patients. J Rheumatol 41:2395–2402
27. Ball EM, Tan AL, Fukuba E, McGonagle D, Grey A, Steiner G et al (2014) A study of erosive phenotypes in lupus arthritis using magnetic resonance imaging and anti-citrullinated protein antibody, anti-RA33 and RF autoantibody status. Rheumatology (Oxford) 53:1835–1843
28. Bolton GG (1989) Coexistent discoid lupus erythematosus and psoriasis: a therapeutic dilemma. J Miss State Med Assoc 30:181–182
29. Kontochristopoulos GJ, Giannadaki M, Doulaveri G, Christoforidou E, Zakopoulou N (2004) Psoriasis coexisting with subacute cutaneous lupus erythematosus. J Eur Acad Dermatol Venereol 18:385–386
30. Ueki H (2005) Koebner phenomenon in lupus erythematosus with special consideration of clinical findings. Autoimmun Rev 4:219–223
31. Kulick KB, Mogavero H Jr, Provost TT, Reichlin M (1983) Serologic studies in patients with lupus erythematosus and psoriasis. J Am Acad Dermatol 8:631–634
32. Cassano N, Buquicchio R, Ranieri V, Loconsole F, Vena GA (2008) Is there an association between antiphospholipid antibodies and psoriasis? J Biol Regul Homeost Agents 22:207–210
33. Prodanovich S, Kirsner RS, Kravetz JD, Ma F, Martinez L, Federman DG (2009) Association of psoriasis with coronary artery, cerebrovascular and peripheral vascular disease and mortality. Arch Dermatol 145:700–703
34. Ungprasert P, Sanguanken A, Upala S, Suksaranjit P (2014) Psoriasis and risk of venous thromboembolism: a systematic review and meta-analysis. QJM 107:793–797
35. Varada S, Gottlieb AB, Merola JF, Saraiya AR, Tintle SJ (2015) Treatment of coexistent psoriasis and lupus erythematosus. J Am Acad Dermatol 72:253–260
36. Winchester D, Duffin KC, Hansen C (2012) Response to ustekinumab in a patient with both severe psoriasis and hypertrophic cutaneous lupus. Lupus 21:1007–1010